Abstract:The action mechanism of matrix metalloproteinases-2 (MMP-2) and tissue inhibitor of metalloproteinases-2 (TIMP-2) in the genesis, development and degeneration of haemangioma was investigated by detecting their expression in the tissue of haemangioma in different phases by using the immunohistochemistry. Fifty paraffin-embedded specimens of skin capillary haemangioma were collected, which were documented in the Department of Pathology, Renmin Hospital of Wuhan University from 2000 to 2006. All samples were stained by regular HE method, and proliferative cell nuclear antigen (PCNA) was tested by immunohistochemical S-P method. The samples were classified according to the Mulliken criteria and the expression pattern of PCNA. Immunohistochemical S-P method was applied to detect the expression of MMP-2 and TIMP-2 in proliferative and degenerative phases of cutaneous capillary haemangioma, and in normal skin tissues. In combination with the detection of the expression of factor VIII-related antigen, it was verified that in haemangioma tissues, the cells expressing MMP-2 and TIMP-2 were vascular endothelial cells. The MMP-2 and TIMP-2 expression was quantitatively analyzed by image analysis system (HPIAS-1000), and one-way ANOVA(107) and SNK(q) test were done to analyze average absorbance (A) and positive area rate of immunohistochemically positive particles by using SPSS11.5. The results showed: (1) Among 50 samples of haemangioma, there were 26 proliferative haemangiomas, and 24 degenerative haemangiomas, respectively; (2) The expression of MMP-2 was weak in normal vascular endothelial cells, cytoplasm of connective tissues and extracellular matrix around blood vessels. The expression of MMP-2 in proliferative group was significantly higher than in degenerative group and control group (normal skin) (P<0.05), but there was no statistically significant difference between the latter two groups; (3) TIMP-2 was highly expressed in normal tissues, degenerative vascular endothelial cells, cytoplasm of connective tissues and extracellular matrix around blood vessels. The expression level of TIMP-2 in proliferative phase was significantly lower than in degenerative phase (P<0.05), and the expression of TIMP-2 in proliferative phase was significantly different from that in degenerative phase and normal tissues (P<0.05). It was concluded that in proliferative phase of haemangioma, MMP-2 may promote over-proliferation of endothelial cells of haemangioma, and in degenerative phase, TIMP-2 can inhibit the proliferation of endothelial cells of haemangioma. The two substances play important roles in the genesis, development and degeneration of haemangiomas.

Real-time PCR Analysis of the Expression of MT1-MMP/ TIMP-2/MMP-2 in Human Vascular Endothelial Cell Lines with Different Origin

Differential Expression of Membrane-type Matrix Metalloproteinase-1 in Distinct Endothelial Cell Lines

The Expression of Membrane-type Matrix Metalloproteinase in Human Vascular Endothelial Cell Lines

[High Glucose and Tea Polyphenols on Expression of Matrix Metalloproteinase-2 and Extracellular Matrix Metalloproteinase Inducer in Human Umbilical Vein Endothelial Cells].

The Expression of MT1-MMP in Human Hematopoietic Cell Lines and Its Influences on the Biological Behaviors of HL60.

Cloning and Expression of the Cdna Encoding Human Tissue Inhibitor of Metalloproteinase-3 and Its Inhibition on Angiogenesis

Effects of hydrogen peroxide on cell proliferation and expression of gelatinase A and its inhibitor in vascular smooth muscle cells

Expression and Correlation of Membrane-type Matrix Metalloproteinases Subfamily and Matrix Metalloproteinase-2 in Human Malignant Hematopoietic Cell Lines

Expression of Vascular Endothelial Growth Factor Receptors in HaCaT Cells

Expressions of TIMP-2, MMP-2 and MT1-MMP in Activated Hepatic Stellate Cells and Their Effects on the Synthesis and Secretion of Extracellular Matrix

Differential expression of matrix metalloproteinases and their tissue inhibitors in human primary cultured prostatic cells and malignant prostate cell lines

Expression of Matrix Metalloproteinase and Its Tissue Inhibitor in Haemangioma

The expression of ADAMTS13 in human microvascular endothelial cells.

Expression of tissue levels of matrix metalloproteinases and tissue inhibitors of metalloproteinases in renal cell carcinoma

[MT1-MMP Up-Regulates VEGF Expression in Human Breast Carcinoma MCF-7 Cells and Induces Tumor Angiogenesis].

Regulation of Matrix Metalloproteinase in Vascularization of Endothelial Cells on Extracellular Matrix Secreted by Mesenchymal Stem Cell Sheet

Effect of integrin αvβ3 on expression and activation of matrix metalloproteinase-2 of human melanoma cells regulated by extracellular matrix

Construction of eukaryotic expression vector of human MT1-MMP and its expression in HepG2 cells and significance

Detection of tissue inhibitors of metalloproteinases in rat cardiac fibroblasts

The Clinical Significance of Matrix Metalloproteinases Production by Bone Marrow Mononuclear Cells from Patients with Chronic Myeloid Leukemia

Differential Gene Expression During Capillary Morphogenesis in A Microcarrier-Based Three-Dimensional in Vitro Model of Angiogenesis with Focus on Chemokines and Chemokine Receptors